American Society of Clinical Oncology (ASCO) shared on LinkedIn:
“Dr. Ashley Sumrall credits the findings from a federally funded clinical trial for her being able to spare patients with brain tumors from chemotherapy, offering fewer side effects, better quality of life, and outcomes that are just as good – or better.
Dr. Sumrall is not just concerned about what a lack of robust, sustained federal cancer research funding could mean for her patients today, but what it could mean for the next generation of researchers and physicians committed to advancing cancer care.
For tomorrow’s patients to see that same progress, we must continue investing in the young scientists and clinicians whose discoveries will shape the future of cancer treatment.
Learn more: Save Research. Stop Cancer.”
Other articles about ASCO on Oncodaily.